Patents by Inventor Perry G. Caimi

Perry G. Caimi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7615365
    Abstract: This invention relates to a method for utilizing less purified starch in fermentation processes. One example is a recombinant E. coli containing a exogenous extracellular isoamylase activity that is capable of utilizing small oligomers containing (1,6) linkages (including but not limited to isomaltose and panose) in fermentations to produce useful products. The invention is useful in large-scale industrial biofermentations by reducing the cost of the substrate carbohydrate.
    Type: Grant
    Filed: September 10, 2007
    Date of Patent: November 10, 2009
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Perry G. Caimi, Mario W. Chen, Vasantha Nagarajan, Jean-Francois Tomb, Siqun Wang, Yuying Zhang
  • Publication number: 20090246846
    Abstract: Strains of Zymomonas were engineered by introducing a chimeric xylose isomerase gene that contains a mutant promoter of the Z. mobilis glyceraldehyde-3-phosphate dehydrogenase gene. The promoter directs increased expression of xylose isomerase, and when the strain is in addition engineered for expression of xylulokinase, transaldolase and transketolase, improved utilization of xylose is obtained.
    Type: Application
    Filed: March 25, 2009
    Publication date: October 1, 2009
    Applicant: E. I. DU PONT DE NEMOURS AND COMPANY
    Inventors: PAUL V. VIITANEN, LUAN TAO, YUYING ZHANG, PERRY G. CAIMI, CAROL M. MCCUTCHEN, LAURA MCCOLE, MIN ZHANG, YAT-CHEN CHOU, MARY ANN FRANDEN
  • Publication number: 20090246876
    Abstract: Identified are mutants of the promoter of the Z. mobilis glyceraldehyde-3-phosphate dehydrogenase gene, which direct improved expression levels of operably linked heterologous nucleic acids. These are high expression promoters useful for expression of chimeric genes in Zymomonas, Zymobacter, and other related bacteria.
    Type: Application
    Filed: March 25, 2009
    Publication date: October 1, 2009
    Applicant: E. I. DU PONT DE NEMOURS AND COMPANY
    Inventors: PAUL V. VIITANEN, LUAN TAO, YUYING ZHANG, PERRY G. CAIMI, LAURA MCCOLE, MIN ZHANG, YAT-CHEN CHOU, CAROL M. MCCUTCHEN, MARY ANN FRANDEN
  • Publication number: 20090221078
    Abstract: Through screening of a Zymomonas mutant library the himA gene was found to be involved in the inhibitory effect of acetate on Zymomonas performance. Xylose-utilizing Zymomonas further engineered to reduce activity of the himA gene were found to have increased ethanol production in comparison to a parental strain, when cultured in medium comprising xylose and acetate.
    Type: Application
    Filed: October 30, 2008
    Publication date: September 3, 2009
    Applicant: E.I. DU PONT DE NEMOURS AND COMPANY
    Inventors: Perry G. Caimi, Yat-Chen Chou, Mary Ann Franden, Kyle Knoke, Luan Tao, Paul V. Viitanen, Min Zhang, Yuying Zhang
  • Publication number: 20090203099
    Abstract: Through screening of a Zymomonas mutant library the himA gene was found to be involved in the inhibitory effect of acetate on Zymomonas performance. Xylose-utilizing Zymomonas strains further engineered to reduce activity of the himA gene were found to have increased ethanol production in comparison to a parental strain, when cultured in mixed-sugars medium comprising xylose, and, in particular, in the presence of acetate.
    Type: Application
    Filed: October 30, 2008
    Publication date: August 13, 2009
    Applicant: E. I. DU PONT DE NEMOURS AND COMPANY
    Inventors: Perry G. Caimi, Yat-Chen Chou, Mary Ann Franden, Kyle Knoke, Luan Tao, Paul V. Viitanen, Min Zhang, Yuying Zhang
  • Patent number: 7560613
    Abstract: This invention relates to isolated nucleic acid fragments encoding trehalose metabolism enzymes, more specifically, alpha, alpha-trehalase, alpha, alpha-trehalose-phosphate synthase or trehalose-6-phosphate phosphatase. The invention also relates to the construction of a recombinant DNA construct encoding all or a portion of the alpha, alpha-trehalase, alpha, alpha-trehalose-phosphate synthase or trehalose-6-phosphate phosphatase, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the alpha, alpha-trehalase, alpha, alpha-trehalose-phosphate synthase or trehalose-6-phosphate phosphatase in a transformed host cell.
    Type: Grant
    Filed: March 21, 2007
    Date of Patent: July 14, 2009
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Perry G. Caimi, Saverio Carl Falco, Zude Weng
  • Publication number: 20090100549
    Abstract: Isolated nucleic acid fragments encoding galactinol synthase are disclosed. Recombinant DNA construct(s) for use in altering expression of endogenous genes encoding galactinol synthase are also disclosed.
    Type: Application
    Filed: December 17, 2008
    Publication date: April 16, 2009
    Inventors: Johan M. Stoop, Stephen M. Allen, Perry G. Caimi
  • Publication number: 20090068704
    Abstract: This invention relates to a method for utilizing less purified starch in fermentation processes. One example is a recombinant E. coli containing a exogenous extracellular isoamylase activity that is capable of utilizing small oligomers containing (1,6) linkages (including but not limited to isomaltose and panose) in fermentations to produce useful products. The invention is useful in large-scale industrial biofermentations by reducing the cost of the substrate carbohydrate.
    Type: Application
    Filed: September 10, 2007
    Publication date: March 12, 2009
    Applicant: EI duPont / Legal
    Inventors: Perry G. Caimi, Mario W. Chen, Vasantha Nagarajan, Jean-Francois Tomb, Siqun Wang, Yuying Zhang
  • Patent number: 7476778
    Abstract: Isolated nucleic acid fragments encoding galactinol synthase are disclosed. Recombinant DNA construct(s) for use in altering expression of endogenous genes encoding galactinol synthase are also disclosed.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: January 13, 2009
    Assignee: E.I. Du Pont
    Inventors: Johan M. Stoop, Perry G. Caimi
  • Publication number: 20080187973
    Abstract: Production of ethanol using a strain of xylose-utilizing Zymomonas with a genetic modification of the glucose-fructose oxidoreductase gene was found to be improved due to greatly reduced production of xylitol, a detrimental by-product of xylose metabolism synthesized during fermentation.
    Type: Application
    Filed: September 27, 2007
    Publication date: August 7, 2008
    Inventors: PAUL V. VIITANEN, Carol M. McCutchen, Mark Emptage, Perry G. Caimi, Min Zhang, Yat-Chen Chou
  • Publication number: 20080172758
    Abstract: Isolated nucleic acid fragments encoding galactinol synthase are disclosed. Recombinant DNA construct(s) for use in altering expression of endogenous genes encoding galactinol synthase are also disclosed.
    Type: Application
    Filed: October 30, 2007
    Publication date: July 17, 2008
    Inventors: Johan M. STOOP, Perry G. CAIMI
  • Patent number: 7294756
    Abstract: Isolated nucleic acid fragments encoding galactinol synthase are disclosed. Recombinant DNA construct(s) for use in altering expression of endogenous genes encoding galactinol synthase are also disclosed.
    Type: Grant
    Filed: June 8, 2005
    Date of Patent: November 13, 2007
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Johan M. Stoop, Stephen M. Allen, Perry G. Caimi
  • Patent number: 7268221
    Abstract: This invention relates to a method for utilizing less purified starch in fermentation processes. One example is a recombinant E. coli containing a exogenous extracellular isoamylase activity that is capable of utilizing small oligomers containing (1,6) linkages (including but not limited to isomaltose and panose) in fermentations to produce useful products. The invention is useful in large-scale industrial biofermentations by reducing the cost of the substrate carbohydrate.
    Type: Grant
    Filed: August 25, 2003
    Date of Patent: September 11, 2007
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Perry G. Caimi, Mario W. Chen, Vasantha Nagarajan Nigarajan, Jean-Francois Tomb, Siqun Wang, Yuying Zhang
  • Patent number: 7253335
    Abstract: This invention relates to isolated nucleic acid fragments encoding fructosyltransferases. More specifically, this invention relates to polynucleotides encoding 1-FFTs, 6-SFTs, or 1-SSTs. The invention also relates to the construction of a recombinant DNA constructs encoding all or a portion of the fructosyltransferases, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the fructosyltransferases in a transformed host cell.
    Type: Grant
    Filed: August 11, 2004
    Date of Patent: August 7, 2007
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Stephen M. Allen, Perry G. Caimi, Johan M. Stoop
  • Patent number: 7214858
    Abstract: This invention relates to isolated nucleic acid fragments encoding trehalose metabolism enzymes, more specifically, alpha, alpha-trehalase, alpha, alpha-trehalose-phosphate synthase or trehalose-6-phosphate phosphatase. The invention also relates to the construction of a recombinant DNA construct encoding all or a portion of the alpha, alpha-trehalase, alpha, alpha-trehalose-phosphate synthase or trehalose-6-phosphate phosphatase, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the alpha, alpha-trehalase, alpha, alpha-trehalose-phosphate synthase or trehalose-6-phosphate phosphatase in a transformed host cell.
    Type: Grant
    Filed: February 13, 2003
    Date of Patent: May 8, 2007
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Perry G. Caimi, Saverio Carl Falco, Zude Weng
  • Patent number: 7176009
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a sucrose phosphate synthase. The invention also relates to the construction of a chimeric gene encoding all or a portion of the sucrose phosphate synthase, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the sucrose phosphate synthase in a transformed host cell.
    Type: Grant
    Filed: August 14, 2003
    Date of Patent: February 13, 2007
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Stephen M. Allen, Perry G. Caimi, Emil M. Orozco, Jr., Mitchell C. Tarczynski
  • Patent number: 7071382
    Abstract: This invention relates to an isolated nucleic acid fragment encoding an apoptosis inhibitory protein. The invention also relates to the construction of a chimeric gene encoding all or a portion of the apoptosis inhibitory protein, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the apoptosis inhibitory protein in a transformed host cell.
    Type: Grant
    Filed: October 7, 2003
    Date of Patent: July 4, 2006
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Rebecca E. Cahoon, Perry G. Caimi, Theodore M. Klein, Michele Morgante, Hajime Sakai, Jennie Bih-Jien Shen, Scott V. Tingey
  • Publication number: 20040229364
    Abstract: This invention relates to isolated nucleic acid fragments encoding trehalose metabolism enzymes, more specifically, alpha, alpha-trehalase, alpha, alpha-trehalose-phosphate synthase or trehalose-6-phosphate phosphatase. The invention also relates to the construction of a recombinant DNA construct encoding all or a portion of the alpha, alpha-trehalase, alpha, alpha-trehalose-phosphate synthase or trehalose-6-phosphate phosphatase, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the alpha, alpha-trehalase, alpha, alpha-trehalose-phosphate synthase or trehalose-6-phosphate phosphatase in a transformed host cell.
    Type: Application
    Filed: February 13, 2003
    Publication date: November 18, 2004
    Inventors: Perry G. Caimi, Saverio Carl Falco, Anthony J. Kinney, J. Antoni Rafalski, Zude Weng
  • Patent number: 6791015
    Abstract: This invention relates to isolated nucleic acid fragments encoding fructosyltransferases. More specifically, this invention relates to polynucleotides encoding 1-FFTs, 6-SFTs, or 1-SSTs. The invention also relates to the construction of a recombinant DNA constructs encoding all or a portion of the fructosyltransferases, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the fructosyltransferases in a transformed host cell.
    Type: Grant
    Filed: October 30, 2001
    Date of Patent: September 14, 2004
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Stephen M. Allen, Perry G. Caimi, Johan M. Stoop
  • Publication number: 20040171023
    Abstract: This invention relates to a method for utilizing less purified starch in fermentation processes. One example is a recombinant E. coli containing a exogenous extracellular isoamylase activity that is capable of utilizing small oligomers containing (1,6) linkages (including but not limited to isomaltose and panose) in fermentations to produce useful products. The invention is useful in large-scale industrial biofermentations by reducing the cost of the substrate carbohydrate.
    Type: Application
    Filed: August 25, 2003
    Publication date: September 2, 2004
    Inventors: Perry G. Caimi, Mario W. Chen, Vasantha Nigarajan, Jean-Francois Tomb, Siqun Wang, Yuying Zhang